GlassScriptPhysician profile
Thien T Tang
NPI 1538127188
$1,619.49
in general payments reported to CMS, 2019-2025
10 companies · $89.83 in 2025
The $89.83 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.00 · 2020: $148 · 2021: $468 · 2022: $316 · 2023: $446 · 2024: $93.82 · 2025: $89.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $629.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $655.43 | 2019-2025 | Invisalign, Invisalign System - Moderate, Itero Element 2 |
| Centrix INC | $199.22 | 2021 | |
| Nobel Biocare USA | $174.81 | 2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $170.44 | 2020-2025 | Arestin, Ossix Plus |
| Allergan, INC. | $169.68 | 2022 | |
| Ormco Corporation | $119.67 | 2021-2023 | Spark |
| Zimvie INC. | $75.51 | 2023 | |
| Madrigal Pharmaceuticals | $27.18 | 2025 | Rezdiffra |
| 3m Company | $13.90 | 2020 | |
| Dentsply Sirona INC | $13.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thien Tang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.